Applications

1154 – Patient Monitor Module for non-invasive assessment of artificial stiffness and titration of anti-hypertensive medication in Chronic Kidney Disease

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

-

Service or technology in this application

The measurement of the AiX for estimation of arterial stiffness and monitoring/titration of anti-hypertensive medication.

Medical condition this application addresses

CKD refers to all conditions of the kidney, lasting at least three months, where a person has had evidence of kidney damage and/or reduced kidney function, regardless of the specific diagnosis of disease or condition causing the disease (National Kidney Foundation of America 2002). Evidence of kidney damage manifests as either urinary protein (proteinuria) or albumin (a type of protein that is a more sensitive and specific marker of kidney disease, albuminuria), blood in the urine (haematuria) or scarring detected by imaging tests.

Application documents